En-risk to de-risk: An iterative human factors framework for scale development in emerging technologies [0.03%]
从高风险到低风险：新兴技术扩展过程中的迭代人因工程框架
Jonathan Kantor,Michael Morrison,Samantha Vanderslott et al.
Jonathan Kantor et al.
Differential response to Janus kinase inhibitors in refractory livedoid vasculopathy: Biomarker-guided therapy may improve clinical response [0.03%]
Janus激酶抑制剂治疗难治性血栓闭塞性脉管炎的差异反应及生物标志物指导治疗可能改善临床疗效
Guoqun Yu,Jinjin Zhu,Yuan Zhang et al.
Guoqun Yu et al.
Psoriatic arthritis and psoriasis have comparable cardiovascular outcomes: Results from a TriNetX Global Network cohort analysis [0.03%]
银屑病性关节炎和银屑病的心血管预后相当：TriNetX全球网络队列分析的结果
Laurent Fauchier,Thibault Lenormand,Lisa Lochon et al.
Laurent Fauchier et al.
Central centrifugal cicatricial alopecia is associated with longer time to diagnosis among scarring alopecias [0.03%]
中央离心性疤痕性斑秃在瘢痕性斑秃中诊断时间较长
Thomas Issa,Alexandra M Klomhaus,Chandra Kasakevich et al.
Thomas Issa et al.
Treatment preferences by disease severity in alopecia areata: A cross-sectional survey study [0.03%]
一项横断面调查研究：按疾病严重程度划分的斑秃治疗偏好
Ursula Biba,Katherine Sanchez,Samantha Gregoire et al.
Ursula Biba et al.
Patient preferences in the benefit-risk assessment of atopic dermatitis treatments in China: A nationwide survey [0.03%]
中国特应性皮炎治疗获益风险评估中的患者偏好：全国性调查研究
Jingyi Yang,Yang Liu,Hengjing Li et al.
Jingyi Yang et al.
Background: Understanding patient preferences is critical for patient-focused drug development, especially in chronic conditions like atopic dermatitis, where treatment benefit-risk profiles vary widely. ...
Predicting outcomes of port-wine stains treated with hematoporphyrin monomethyl ether photodynamic therapy (HMME-PDT): An observational study using multimodal deep learning [0.03%]
基于多模态深度学习的血卟啉单甲醚光动力疗法治疗血管瘤预后评估：一项观察性研究
Jinjin Zhu,Chunhui Xie,Yan Li et al.
Jinjin Zhu et al.
Telemedicine visits for new onychomycosis diagnoses result in fewer antifungal prescriptions than in-person care: A retrospective cohort study [0.03%]
远程医疗对甲癣的新诊断比当面就诊开具较少的抗真菌药物处方：一项回顾性队列研究
Sonya V Gupta,Kevin Chen,Christina Tang et al.
Sonya V Gupta et al.
Off-label use of abrocitinib in dermatology: A systematic literature review with narrative summary [0.03%]
阿布昔替尼在皮肤病中的超适应症使用：系统文献回顾及综述性总结
Zheng Su,Chen Sun,Wen-Hui Yao et al.
Zheng Su et al.
Burden of acne vulgaris, psoriasis, atopic dermatitis, and urticaria in individuals under 20 years of age in China and globally, 1990-2021: A systematic analysis with 10-year forecast [0.03%]
中国及全球1990年～2021年＜20岁人群寻常痤疮、银屑病、特应性皮炎和荨麻疹疾病负担及十年预测的系统分析
Jiawen Wu,Yuanqin Wang,Yuxin Qing et al.
Jiawen Wu et al.